Efficacy of cyclosporine treatment on severe recalcitrant nodular vasculitis

Dermatol Ther. 2020 Nov;33(6):e13870. doi: 10.1111/dth.13870. Epub 2020 Aug 18.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cyclosporine* / therapeutic use
  • Humans
  • Immunosuppressive Agents / therapeutic use
  • Vasculitis*

Substances

  • Immunosuppressive Agents
  • Cyclosporine